Ouro Fino Saúde Animal Participações S.A (OFSA3)
Sao Paulo Exchange · Brazil · prices in BRL · close of 16 Oct 2026
Key indicators
| Last close | BRL 29.65 |
|---|---|
| 52-week range | 20.06 – 34.69 |
| Return, 1 month / 3 months | +14.0% / +17.2% |
| Return, 1 year / 3 years | +36.8% / +54.7% |
| Trend | Uptrend |
| RSI (14) | 67 |
| Volatility (1 year) | 36.0% |
| Worst drawdown (1 year) | -27.4% |
| Average daily value traded | 0.17M BRL |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ouro Fino Saúde Animal Participações is a Brazilian animal health company that develops and makes veterinary products for livestock and companion animals. Its range covers vaccines, medicines and other health products used by cattle, poultry, swine and pet owners, along with farmers and veterinarians who raise and care for animals. The company is based in Cravinhos, in the state of São Paulo, and serves the Brazilian agricultural and pet markets.
Ouro Fino Saúde Animal Participações S.A trades under the code OFSA3 on the Sao Paulo Exchange in Brazil, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ouro Fino Saúde Animal Participações S.A (OFSA3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 29.65 on 16 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 456 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 36.8% and over the last three months it rose 17.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.9% | ||
| From 52-week high | -12.2% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 17.2% | ||
| 6-month return | -2.3% | ||
| 12-month return, skipping the last month | 20.1% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.4% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.17M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.5% |
|---|---|
| 1 month | +14.0% |
| 3 months | +17.2% |
| 6 months | −2.3% |
| 1 year | +36.8% |
| 3 years | +54.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 26.58 / 27.24 |
|---|---|
| Golden / death cross (60 days) | Death, 30 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.84 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Dec 2025 | BRL 0.9299 |
| 17 Apr 2025 | BRL 0.1506 |
| 20 Dec 2024 | BRL 0.5766 |
| 29 Apr 2024 | BRL 0.3369 |
| 14 Apr 2023 | BRL 0.1967 |
| 16 Dec 2022 | BRL 0.4388 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.